ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG
Product details
Registration number: SIN16153P
Classification: Prescription Only
Active ingredients:
- Glycopyrronium bromide equivalent to Glycopyrronium
- Indacaterol acetate equivalent to Indacaterol
- Mometasone furoate
Strength:
- 50 mcg
- 150 mcg
- 160 mcg
Dosage form: POWDER, METERED
Route: RESPIRATORY (INHALATION)
Registrant: NOVARTIS (SINGAPORE) PTE LTD
ATC code: R03AL12
HSA approval date: 14 April 2021
Manufacturer(s):
- Siegfried Barberá S.L.
- Novartis Pharma Schweizerhalle AG (Drug Product Intermediate)
Manufacturing country/countries: SPAIN; SWITZERLAND
What are the HSA registration number and classification for ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16153P
Classification: Prescription Only
What active ingredients and strength are recorded for ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Glycopyrronium bromide equivalent to Glycopyrronium
- Indacaterol acetate equivalent to Indacaterol
- Mometasone furoate
Strength:
- 50 mcg
- 150 mcg
- 160 mcg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG?
According to the HSA dataset updated 7 August 2026:
Dosage form: POWDER, METERED
Route: RESPIRATORY (INHALATION)
Who is the recorded registrant for ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Siegfried Barberá S.L.
- Novartis Pharma Schweizerhalle AG (Drug Product Intermediate)
Manufacturing country/countries: SPAIN; SWITZERLAND
Where can I look up ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16153P or the exact product name ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG. The general register link does not preselect this product.
What are the source dates for this ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16153P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)